Atlas Trials

Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain

Clinical trial NCT00458510 · COMPLETED

Trial details

NCT number
NCT00458510
Sponsor
Archimedes Development Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cancers, Pain
Start date
2007-01-01
Primary completion
2011-10-01
Enrollment
403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.